Product
FirstCare® Allergy Relief Soft Chews - Diphenhydramine HCl, 25 mg | Antihistamine (20 Count)
FirstCare® Gas Relief Soft Chews - Simethicone 250 mg | (20 Count)
Cushion Grip - Thermoplastic Denture Adhesive
Nitro-Dur®
Methylphenidate Hydrochloride Extended Release Tablets
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product)
Strength | NDC/SKU Numbers | Pack Size |
---|---|---|
5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg | 72516-016-01, 72516-015-01, 72516-014-01, 72516-013-01, 72516-012-01, 72516-011-01 | 100 Tablets |
Indication : Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
Bioequivalent : ADDERALL®
Marketed by : Oryza Pharmaceuticals Inc.
FirstCare Lidocaine 4% Gel Patch
Strength | NDC/SKU Numbers | Pack Size |
---|---|---|
4% (10 cm x 14 cm) | 71594-602-05 | 5 patches |
Indication : Temporarily relieves minor pain
Marketed by : Alexso
Click to ViewMilnacipran Tablets Tentatively Approved
Strength : 12.5mg, 25mg, 50mg
Bioequivalent to : Savella®
Indication : Management of fibromyalgia
Fingolimod Capsules Tentatively Approved
Strength : 0.5mg Capsules
Bioequivalent to : Gilenya®
Indication : Relapsing forms of multiple sclerosis (MS).
Lurasidone Tablets Tentatively Approved
Strength : 20mg, 40mg, 60mg, 80mg, 120mg
Bioequivalent to : Latuda®
Indication : Treatment of schizophrenia and depressive episodes that happen with bipolar disorder.
Dronedarone Tablets Pending Approval
Strength : 400 mg
Bioequivalent to : Multaq
Indication : To reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF)
Lidocaine 5% Patch Pending Approval
Strength : 5%
Bioequivalent to : Lidoderm®
Indication : For relief of pain associated with post-herpetic neuralgia